Table 3 Prevalence of the noncommunicable diseases (NCD) at baseline of the Shahrekord PERSIAN Cohort Study, by sex and residence area

Type 2 diabetes^a

968 (9.8)

408 (8.8)

560 (10.7)

0.002

751 (10.9)

217 (7.2)

<0.001

Hypertension^a

1694 (17.1)

632 (13.6)

1062 (20.2)

<0.001

1275 (18.5)

419 (13.9)

<0.001

Cardiac ischemic disease

566 (5.7)

321 (6.9)

245 (4.7)

<0.001

433 (6.3)

133 (4.4)

<0.001

Myocardial infraction

127 (1.3)

100 (2.1)

27 (0.5)

<0.001

111 (1.6)

16 (0.5)

<0.001

Stroke

93 (0.9)

51 (1.1)

42 (0.8)

0.125

65 (0.9)

28 (0.9)

0.959

Renal failure

60 (0.6)

31 (0.7)

29 (0.6)

0.461

48 (0.7)

12 (0.4)

0.079

Fatty liver disease

1476 (14.9)

542 (11.7)

934 (17.8)

<0.001

1231 (17.9)

245 (8.1)

<0.001

Chronic lung disease

410 (4.1)

183 (3.9)

227 (4.3)

0.340

343 (5.0)

67 (2.2)

<0.001

Thyroid disease

1145 (11.6)

215 (4.6)

930 (17.7)

<0.001

976 (14.2)

169 (5.6)

<0.001

Kidney stone

2065 (20.8)

1189 (25.6)

876 (16.7)

<0.001

1511 (21.9)

554 (18.4)

<0.001

Rheumatic disease

470 (4.7)

139 (3.0)

331 (6.3)

<0.001

370 (5.4)

100 (3.3)

<0.001

Cancers

71 (0.7)

21 (0.05)

50 (1.0)

0.003

62 (0.9)

9 (0.3)

0.001

Gallstone

406 (4.1)

93 (2.0)

313 (6.0)

<0.001

315 (4.6)

91 (3.0)

<0.001

Multiple sclerosis

19 (0.2)

6 (0.1)

13 (0.2)

0.179

17 (0.2)

2 (0.1)

0.059

Depression

1610 (16.3)

432 (9.3)

1178 (22.4)

<0.001

1272 (18.4)

338 (11.2)

<0.001

Gastroesophageal reflux

2976 (30.0)

1229 (26.4)

1747 (33.2)

<0.001

2003 (29.0)

973 (32.3)

<0.001

Multimorbidity^b

3273 (32.4)

1188 (24.9)

2085 (39.1)

<0.001

2578 (36.6)

695 (22.8)

<0.001

No NCDs

3983 (39.5)

2179 (45.8)

1804 (33.9)

2449 (34.8)

1534 (50.4)

One NCDs

Two NCDs

≥3 NCDs

2819 (28)

1680 (16.6)

1593 (15.9)

1387 (29.2)

703 (14.8)

485 (10.2)

1432 (26.9)

977 (18.4)

1108 (20.8)

<0.001

2007 (28.6)

1259 (17.9)

1319 (18.7)

812 (26.7)

421 (13.9)

274 (9)

<0.001